Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE (0.20%), DAX30 (0.08%), CAC40 +0.05%

Aug 19 ,2024

  • Synopsis

    • European equity markets set to open mixed amidst mostly higher session in Asia and flat S&P 500 futures. Greater China markets outperforming with property developers notable gainers in Hong Kong. JGB yield curve bear steepening while Treasuries little changed. Yen strength the main development in FX markets. Offshore yuan strengthening alongside Aussie and kiwi, dollar steady elsewhere. Crude and gold seeing small declines. Bitcoin retreating after failure at $60K.

    • Focus this week turns to Riksbank interest rate decision, the annual Jackson Hole economic policy symposium, Eurozone, France, Germany and UK Aug flash manufacturing/services PMIs. Attention will also be on government formation negotiations in Belgium and who France's Macron will pick as the country's next Prime Minister. Reportedly, the French President is to meet with party leaders on Fri (23rd). Also, campaigning for next month's regional elections in the German states of Brandenburg, Saxony and Thuringia is putting strains on the stability of Chancellor Scholz's coalition government. On the agenda for today, deadline for Bart De Wever to report back to King Filip ( meeting 14:00 CET) on progress if Belgium government coalition talks. Chancellor Scholz speaks at the traditional reception of Stoppelmarkt, and in the evening hold the next Chancellor's TALK series in Bremen. Finland central bank's Rehn speech at 23:30CET at event hosted by EACCNY.

    • Little of note on the earnings and macro calendars for today.

  • Politics/Macro/World News

    • Interest rate cut fuels immediate upturn in UK property market (The Guardian)

      • UK Aug house price index +0.8% y/y vs prior +0.4%; (1.5%) m/m vs prior (0.4%); now sees 2024 +1% y/y vs prior (1%) - Rightmove

    • Starmer Faces Growing UK Strike Action in Next Test for Premier (Bloomberg)

    • Germany plans to cut Ukraine aid to just 6pc of current total (The Telegraph)

    • No respite for Turkey's economy as rates set to stay at 50% (Bloomberg)

  • Top company news

    • Earnings/updates

      • FLOW.NA (Flow Traders) -- July 2024 market statistics

      • GURN.SW (Gurit Holding) -- H1 EPS (CHF0.02) vs year-ago CHF1.54

      • BRNK.GR (Branicks Group) -- prelim H1 FFO €19.4M vs year-ago €22.4M; bridge financing reduced by a further €80M

    • M&A

      • ERIC.B.SS (Telefonaktiebolaget LM Ericsson) -- Ericsson announces sale of iconectiv to Koch Equity Development for ~SEK 10.6B ($1.0B)

      • EQT.SS (EQT AB) -- EQT in exclusive discussions to acquire Compass Education - Australian Financial Review

      • VAR1.GR (VARTA)

        • reaches agreement with financial creditors and strategic investors on a restructuring plan

        • Porsche (P911.GR) and Varta deepen strategic partnership

      • CVC.NA (CVC Capital Partners) -- among buyout firms preparing to submit bids for controlling stake in Grant Thornton UK - Sky News

    • Healthcare

      • BAVA.DC (Bavarian Nordic) -- Provides Statement on Mpox Vaccine Supply and Collaboration with African and Global Stakeholders (17-Aug)

      • HYL.BB (Hyloris Pharmaceuticals) -- secures a development partner for HY-095

      • 4568.JP (Daiichi Sankyo) -- receives China NMPA approval for Enhertu for treatment of HER2-positive gastric or gastroesophageal junction adenocarcinoma

      • 068270.KS (Celltrion) -- launches phase III trial of CTP13 in rheumatoid arthritis patients

    • Other

      • AHT.LN (Ashtead Group) -- Glass Lewis urges Ashtead shareholders to vote against plans for American-style executive packages - London Times

      • ACS.SM (ACS SA) -- ACS Group and Acciona to build and operate SR400 Express Lane in Atlanta, GA for 50 years

      • BWB.GR (Baader Bank) -- extends cooperation agreement in place with its B2B partner sino AG for several years

      • HSX.LN (Hiscox) -- calls on policymakers for better risk management of new building projects as insurers and reinsurers ramp up prices - FT, citing CEO

      • TGS.NO (TGS-NOPEC Geophysical Co.) -- launches PAMA 3D Phase 1 survey in the Equatorial Margin of Brazil

  • Key rating changes

    • Upgrades

      • DEMANT.DC (Demant) -- to hold from reduce at Kepler Cheuvreux

      • EBRO.SM (Ebro Foods) -- to outperform from neutral at Santander

      • FFARM.NA (ForFarmers) -- to hold from reduce at Kepler Cheuvreu

      • HOLN.SW (Holcim) -- to buy from hold at Deutsche Bank

      • MT.NA (ArcelorMittal) -- to overweight from equal weight at Barclays

      • NIBE.B.SS (NIBE Industrier) -- to hold from sell at ABG Sundal Collier

      • TPK.LN (Travis Perkins) -- to add from hold at Peel Hunt

      • VWS.DC (Vestas Wind Systems) -- to neutral from underperform at BNP Paribas Exane

    • Downgrades

      • KARNEL.B.SS (Karnell Group) -- to hold from buy at SEB

      • VWS.DC (Vestas Wind Systems) -- to hold from buy at Deutsche Bank

      • SCATC.NO (Scatec) -- to hold from buy at SEB

      • OSB.LN (OSB Group) -- to hold from add at Peel Hunt

    • Initiations

      • HOLM.B.SS (Holmen) -- equal weight at Barclays

      • VIT.B.SS (Vitec Software Group) -- buy at Pareto

    • Other Actions

      • SGL.GR (SGL Carbon) -- transferred buy at Stifel; prior rating was buy

  • Data

    • Nikkei (1.75%) to 37394.75

    • Hang Seng +0.87% to 17581.74

    • Shanghai Composite +0.39% to 2890.55

    • S&P futures (0.3) vs prior close of 5578.3

    • €-$ +0.0020 or +0.18% to 1.1048

    • $-¥ (2.27) or (1.54%) to 145.43

    • €-¥ (2.20) or (1.35%) to 160.66

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE